HC
HCA.US HCA Healthcare, Inc.
- Market cap
- USD 104B
- P/E
- 16.6x
- P/B
- 291.34x
- ROE
- -
- Dividend yield
- 0.65%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is HCA.US undervalued?
Graham numberThe Graham number of HCA Healthcare, Inc. cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
HCA Healthcare, Inc. fundamental analysis
No fundamental analysis for HCA Healthcare, Inc. yet.
HCA Healthcare, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About HCA Healthcare, Inc.
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-ba…
Full company profileHCA Healthcare, Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
HCA Healthcare, Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 41.5B | 43.6B | 46.7B | 51.3B | 51.5B | 58.8B | 60.2B | 65.0B | 70.6B | 75.6B | 78.9B |
| Gross Profit | 34.6B | 36.3B | 39.0B | 42.9B | 43.2B | 22.5B | 23.2B | 25.6B | 28.7B | 31.4B | 11.9B |
| Operating Income | 6.20B | 6.06B | 6.64B | 7.22B | 7.26B | 9.68B | 9.05B | 9.63B | 10.5B | 12.0B | 11.9B |
| EBITDA | 8.48B | 8.20B | 9.37B | 9.66B | 9.74B | 14.3B | 13.3B | 12.7B | 13.9B | 15.6B | 15.7B |
| Net Income | 2.89B | 2.22B | 3.79B | 3.51B | 3.75B | 6.96B | 5.64B | 5.24B | 5.76B | 6.78B | 6.53B |
| EPS | 7.30 | 5.95 | 11 | 10 | 11 | 21 | 19 | 19 | 22 | 29 | 30 |
| Balance Sheet | |||||||||||
| Total Assets | 33.8B | 36.6B | 39.2B | 45.1B | 47.5B | 50.7B | 52.4B | 56.2B | 59.5B | 60.7B | 63.5B |
| Total Liabilities | 39.4B | 41.6B | 42.1B | 45.6B | 44.6B | 49.3B | 52.5B | 55.2B | 59.0B | 63.5B | 68.1B |
| Shareholders' Equity | -5.63B | -5.00B | -2.92B | -565M | 2.89B | 1.49B | -73.0M | 1.06B | 555M | -2.77B | -8.08B |
| Cash & Short-term Investments | 646M | 732M | 502M | 621M | 1.79B | 1.45B | 908M | 935M | 2.02B | 1.04B | 908M |
| Total Debt | 31.4B | 33.1B | 32.8B | 35.6B | 33.1B | 36.7B | 40.2B | 41.9B | 45.2B | 48.7B | 52.4B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 5.65B | 5.43B | 6.76B | 7.60B | 9.23B | 8.96B | 8.52B | 9.43B | 10.5B | 12.6B | 11.7B |
| Capital Expenditure | 2.76B | 3.02B | 3.57B | 4.16B | 2.84B | 3.58B | 4.40B | 4.74B | 4.88B | 4.94B | 4.94B |
| Free Cash Flow | 2.89B | 2.41B | 3.19B | 3.44B | 6.40B | 5.38B | 4.13B | 4.69B | 5.64B | 7.69B | 6.80B |
| Ratios | |||||||||||
| ROE | - | - | - | - | 129.8% | 467.2% | - | 494.5% | 1,037.8% | - | - |
| ROA | 8.6% | 6.1% | 9.7% | 7.8% | 7.9% | 13.7% | 10.8% | 9.3% | 9.7% | 11.2% | 10.3% |
| Net Profit Margin | 7.0% | 5.1% | 8.1% | 6.8% | 7.3% | 11.8% | 9.4% | 8.1% | 8.2% | 9.0% | 8.3% |
| Debt to Equity | - | - | - | - | 11.43x | 24.66x | - | 39.49x | 81.51x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
HCA Healthcare, Inc. dividends
- Dividend yield
- 0.65%
- Forward dividend
- 3.12 USD
- Payout ratio
- 10.0%
- Ex-dividend date
- Dec 15, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 679M | 2.94 | 10.0% |
| 2024 | USD 690M | 2.64 | 12.0% |
| 2023 | USD 661M | 2.39 | 12.6% |
| 2022 | USD 653M | 2.22 | 11.6% |
| 2021 | USD 624M | 1.90 | 9.0% |
| 2020 | USD 153M | 0.44 | 4.1% |
| 2019 | USD 550M | 1.58 | 15.7% |
| 2018 | USD 487M | 1.37 | 12.9% |
| 2017 | USD 448M | 1.20 | 20.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns HCA Healthcare, Inc.
- Insiders 17.39%
- Institutions 79.55%
- Public & others 3.07%
- Shares outstanding 209M
- Free float 137M
Top funds holding HCA.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 4.47M | 2.14% | -9.52% | Sep 2026 |
| American Funds Growth Fd of Amer A | 3.93M | 1.88% | +25.25% | Sep 2026 |
| Vanguard 500 Index Investor | 3.87M | 1.85% | -6.30% | Sep 2026 |
| First Eagle Global A | 2.19M | 1.05% | 0.00% | Sep 2026 |
| iShares Core S&P 500 ETF | 1.96M | 0.94% | +0.17% | Oct 2026 |
| Fidelity 500 Index | 1.91M | 0.92% | -5.08% | Sep 2026 |
| State Street® SPDR® S&P 500® ETF | 1.79M | 0.86% | -0.25% | Oct 2026 |
| Vanguard Windsor II Inv | 1.48M | 0.71% | -4.40% | Sep 2026 |
| Vanguard Health Care Inv | 1.45M | 0.70% | -2.52% | Sep 2026 |
| Vanguard MStar Value Index Investor | 1.34M | 0.64% | -9.63% | Sep 2026 |
| Vanguard Wellington Inv | 1.11M | 0.53% | -16.55% | Sep 2026 |
| State Street®HlthCrSelSectSPDR®ETF | 1.08M | 0.52% | +0.87% | Oct 2026 |
| Vanguard Institutional Index I | 779K | 0.37% | -6.17% | Sep 2026 |
| Hartford Dividend and Growth Y | 543K | 0.26% | +19.22% | Sep 2026 |
| Fidelity Contrafund | 486K | 0.23% | +37.17% | Sep 2026 |
| Vanguard Health Care ETF | 475K | 0.23% | +0.13% | Sep 2026 |
| Invesco S&P 500® Equal Weight ETF | 468K | 0.22% | +0.16% | Oct 2026 |
| JPM America Equity A dist USD | 430K | 0.21% | -1.01% | Sep 2026 |
| State Street® SPDR® Port S&P 500® ETF | 410K | 0.20% | -0.07% | Oct 2026 |
| American Funds IS® Growth 1 | 401K | 0.19% | 0.00% | Sep 2026 |
Top institutions holding HCA.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 13.0M | 6.23% | -2.69% | Jun 2026 |
| Vanguard Capital Management, LLC | 10.1M | 4.86% | -0.36% | Jun 2026 |
| Sanders Capital, LLC | 8.79M | 4.21% | -0.41% | Sep 2026 |
| State Street Corp | 7.47M | 3.58% | -0.94% | Jun 2026 |
| Arnhold & S. Bleichroeder Advisers, LLC | 6.59M | 3.16% | +102.52% | Jun 2026 |
| Wellington Management Company LLP | 4.71M | 2.25% | +20.47% | Jun 2026 |
| Geode Capital Management, LLC | 3.67M | 1.76% | -0.66% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 2.71M | 1.30% | -1.63% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 2.59M | 1.24% | +12.72% | Jun 2026 |
| The Goldman Sachs Group Inc | 2.46M | 1.18% | +15.37% | Jun 2026 |
| JPMorgan Chase & Co | 2.29M | 1.09% | -7.15% | Jun 2026 |
| Arrowstreet Capital Limited Partnership | 2.21M | 1.06% | +2.04% | Jun 2026 |
| NORGES BANK | 2.15M | 1.03% | -20.67% | Jun 2026 |
| Capital Research & Mgmt Co - Division 3 | 2.14M | 1.02% | +11.38% | Sep 2026 |
| Capital World Investors | 1.98M | 0.95% | +0.24% | Jun 2026 |
| Northern Trust Corp | 1.71M | 0.82% | -2.49% | Jun 2026 |
| FMR Inc | 1.63M | 0.78% | -62.91% | Jun 2026 |
| Amvescap Plc. | 1.53M | 0.73% | +6.33% | Jun 2026 |
| Nordea Investment Mgmt Bank Demark A/s | 1.40M | 0.67% | -1.93% | Sep 2026 |
| Barclays PLC | 1.32M | 0.63% | +5.68% | Jun 2026 |
HCA Healthcare, Inc. company profile
- Company name
- HCA Healthcare, Inc.
- Ticker
- HCA.US
- Exchange
- USA Stocks
- Listed since
- Mar 10, 2011
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 230,000
- Fiscal year end
- December
- Address
- One Park Plaza, Nashville, TN, United States, 37203
- Phone
- 615 344 9551
- Website
- hcahealthcare.com
About HCA Healthcare, Inc.
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
HCA Healthcare, Inc. management
10- Mr. Samuel N. HazenCEO & Director · born 1960
- Mr. Michael A. MarksCFO & Executive VP · born 1970
- Mr. Jon Mack FosterExecutive VP & COO · born 1962
- Mr. Michael R. McAleveyExecutive VP and Chief Legal & Administrative Officer · born 1964
- Dr. Michael S. Cuffe M.B.A., M.D.Executive Officer · born 1966
- Dr. Thomas F. Frist Jr., M.D.Founder & Chairman Emeritus · born 1939
- Mr. Christopher F. WyattSenior VP, Principal Accounting Officer & Controller · born 1978
- Mr. Chad J. WassermanSenior VP & Chief Information Officer
- Mr. Frank George Morgan C.F.A.Vice President of Investor Relations
- Ms. Wendy WarrenSenior VP and Chief Ethics & Compliance Officer